Analysed Cogent Biosciences Inc (COGT:NASDAQ) News Sources
Cogent Biosciences Inc. (COGT) Set for Bezuclastinib Launch, Awaiting FDA Approval
Yahoo Finance Singapore
Cogent Biosciences, Inc.: Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
FinanzNachrichten.de
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cogent Biosciences (COGT), Aquestive Therapeutics (AQST) and Merck & Company (MRK)
The Globe and Mail
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
MarketWatch
What is the current price of Cogent Biosciences Inc (COGT:NASDAQ)?
The current price of Cogent Biosciences Inc (COGT:NASDAQ) is $37.08.
Cogent Biosciences Inc (COGT:NASDAQ) absolute price change since previous trading day?
The absolute price change of Cogent Biosciences Inc (COGT:NASDAQ) since the previous trading day is $-0.38.
Cogent Biosciences Inc (COGT:NASDAQ) percentage price change since previous trading day?
The percentage price change of Cogent Biosciences Inc (COGT:NASDAQ) since the previous trading day is -1.01%.
What is This Week's average sentiment score for Cogent Biosciences Inc (COGT:NASDAQ)?
This Week's average sentiment score for Cogent Biosciences Inc (COGT:NASDAQ) is 62 out of 100.
What is This Week's average sentiment for Cogent Biosciences Inc (COGT:NASDAQ)?
This Week's sentiment for Cogent Biosciences Inc (COGT:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.